Dr. Jen Caudle Breaks Down Antiviral Covid Drug and J&J Booster

As the coronavirus pandemic continues, the push to authorize a number of treatments has come into focus. Johnson and Johnson have now filed an emergency authorization of its Covid-19 vaccine booster. In addition, the drug maker Merck has announced its new experimental drug cuts the risk of death and hospitalization related to COVID-19 by 50% when given to patients recently infected with the virus. So how does Merck's new anti-viral covid pill help beat the virus and who will be allowed to take it? Dr. Jen Caudle, family physician and associate professor at Rowan University, joined None of the Above to answer your current Covid questions.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.